Extracorporeal therapy requirements for patients with acute renal failure

William R. Clark, Bruce A. Mueller, Michael Kraus, William L. Macias

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Renal replacement therapy (RRT) requirements for critically ill patients with acute renal failure (ARF) depend on numerous factors, including the degree of hypercatabolism, patient size, and desired level of metabolic control. However, the current practice at many institutions is to prescribe generally similar amounts of RRT to ARF patients essentially without regard for the above factors. In this study, a computer based model designed to permit individualized RRT prescription to ARF patients was developed. The critical input parameter is the desired level of metabolic control, which is the time-averaged BUN (BUN(a)) or steady-state BUN (BUN(s)) for intermittent hemodialysis (IHD) or continuous RRT (CRRT), respectively. The basis for the model was a group of 20 patients who received uninterrupted CRRT for at least 5 days. In these patients, the normalized protein catabolic rate (nPCR) increased linearly (r = 0.974) from 1.55 ± 0.14 g/kg per day (mean ± SEM) on day 1 to 1.95 ± 0.15 g/kg per day on day 6. The daily urea generation rate (G), determined from the above linear relationship, was utilized to produce BUN versus time curves by the direct quantification method for simulated patients of varying dry weights (50 to 100 kg) who received variable CRRT urea clearances (500 to 2000 ml/h). Steady state BUN versus time profiles for the same simulated patient population treated with IHD regimens (K = 180 ml/min, T = 4 h) of variable frequency were generated by use of a variable volume, single-pool kinetic model. From these profiles, regression lines of required IHD frequency (per week) versus patient weight for desired BUN(a) values of 60, 80, and 100 mg/dl were obtained. Regression lines of required CRRT urea K (ml/h) versus patient weight for desired BUN(s) values of 60, 80, and 100 mg/dl were also generated. For the attainment of intensive IHD metabolic control (BUN(a) = 60 mg/dl) at steady state, a required treatment frequency of 4.4 dialyses per week is predicted for a 50-kg patient. However, the predicts that the same degree of metabolic control cannot be achieved even with daily IHD therapy in patients ≤ 90 kg. On the other hand, for the attainment of intensive CRRT metabolic control (BUN(s) = 60 mg/dl), required urea clearance rates of approximately 900 ml/h and 1900 ml/h are predicted for 50- and 100-kg patients, respectively. This model suggests that, for many patients, rigorous azotemia control equivalent to that readily attainable with most CRRT can only be achieved with intensive that readily IHD regimens. Following prospective clinical validation, this methodology may be a useful RRT prescription tool for critically ill ARF patients.

Original languageEnglish
Pages (from-to)804-812
Number of pages9
JournalJournal of the American Society of Nephrology
Volume8
Issue number5
StatePublished - May 1997

Fingerprint

Acute Kidney Injury
Blood Urea Nitrogen
Renal Replacement Therapy
Renal Dialysis
Therapeutics
Urea
Weights and Measures
Critical Illness
Prescriptions
Azotemia
Computer Simulation

ASJC Scopus subject areas

  • Nephrology

Cite this

Clark, W. R., Mueller, B. A., Kraus, M., & Macias, W. L. (1997). Extracorporeal therapy requirements for patients with acute renal failure. Journal of the American Society of Nephrology, 8(5), 804-812.

Extracorporeal therapy requirements for patients with acute renal failure. / Clark, William R.; Mueller, Bruce A.; Kraus, Michael; Macias, William L.

In: Journal of the American Society of Nephrology, Vol. 8, No. 5, 05.1997, p. 804-812.

Research output: Contribution to journalArticle

Clark, WR, Mueller, BA, Kraus, M & Macias, WL 1997, 'Extracorporeal therapy requirements for patients with acute renal failure', Journal of the American Society of Nephrology, vol. 8, no. 5, pp. 804-812.
Clark, William R. ; Mueller, Bruce A. ; Kraus, Michael ; Macias, William L. / Extracorporeal therapy requirements for patients with acute renal failure. In: Journal of the American Society of Nephrology. 1997 ; Vol. 8, No. 5. pp. 804-812.
@article{92a65ccfa3b94cfeb50d142125a3eaae,
title = "Extracorporeal therapy requirements for patients with acute renal failure",
abstract = "Renal replacement therapy (RRT) requirements for critically ill patients with acute renal failure (ARF) depend on numerous factors, including the degree of hypercatabolism, patient size, and desired level of metabolic control. However, the current practice at many institutions is to prescribe generally similar amounts of RRT to ARF patients essentially without regard for the above factors. In this study, a computer based model designed to permit individualized RRT prescription to ARF patients was developed. The critical input parameter is the desired level of metabolic control, which is the time-averaged BUN (BUN(a)) or steady-state BUN (BUN(s)) for intermittent hemodialysis (IHD) or continuous RRT (CRRT), respectively. The basis for the model was a group of 20 patients who received uninterrupted CRRT for at least 5 days. In these patients, the normalized protein catabolic rate (nPCR) increased linearly (r = 0.974) from 1.55 ± 0.14 g/kg per day (mean ± SEM) on day 1 to 1.95 ± 0.15 g/kg per day on day 6. The daily urea generation rate (G), determined from the above linear relationship, was utilized to produce BUN versus time curves by the direct quantification method for simulated patients of varying dry weights (50 to 100 kg) who received variable CRRT urea clearances (500 to 2000 ml/h). Steady state BUN versus time profiles for the same simulated patient population treated with IHD regimens (K = 180 ml/min, T = 4 h) of variable frequency were generated by use of a variable volume, single-pool kinetic model. From these profiles, regression lines of required IHD frequency (per week) versus patient weight for desired BUN(a) values of 60, 80, and 100 mg/dl were obtained. Regression lines of required CRRT urea K (ml/h) versus patient weight for desired BUN(s) values of 60, 80, and 100 mg/dl were also generated. For the attainment of intensive IHD metabolic control (BUN(a) = 60 mg/dl) at steady state, a required treatment frequency of 4.4 dialyses per week is predicted for a 50-kg patient. However, the predicts that the same degree of metabolic control cannot be achieved even with daily IHD therapy in patients ≤ 90 kg. On the other hand, for the attainment of intensive CRRT metabolic control (BUN(s) = 60 mg/dl), required urea clearance rates of approximately 900 ml/h and 1900 ml/h are predicted for 50- and 100-kg patients, respectively. This model suggests that, for many patients, rigorous azotemia control equivalent to that readily attainable with most CRRT can only be achieved with intensive that readily IHD regimens. Following prospective clinical validation, this methodology may be a useful RRT prescription tool for critically ill ARF patients.",
author = "Clark, {William R.} and Mueller, {Bruce A.} and Michael Kraus and Macias, {William L.}",
year = "1997",
month = "5",
language = "English",
volume = "8",
pages = "804--812",
journal = "Journal of the American Society of Nephrology : JASN",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "5",

}

TY - JOUR

T1 - Extracorporeal therapy requirements for patients with acute renal failure

AU - Clark, William R.

AU - Mueller, Bruce A.

AU - Kraus, Michael

AU - Macias, William L.

PY - 1997/5

Y1 - 1997/5

N2 - Renal replacement therapy (RRT) requirements for critically ill patients with acute renal failure (ARF) depend on numerous factors, including the degree of hypercatabolism, patient size, and desired level of metabolic control. However, the current practice at many institutions is to prescribe generally similar amounts of RRT to ARF patients essentially without regard for the above factors. In this study, a computer based model designed to permit individualized RRT prescription to ARF patients was developed. The critical input parameter is the desired level of metabolic control, which is the time-averaged BUN (BUN(a)) or steady-state BUN (BUN(s)) for intermittent hemodialysis (IHD) or continuous RRT (CRRT), respectively. The basis for the model was a group of 20 patients who received uninterrupted CRRT for at least 5 days. In these patients, the normalized protein catabolic rate (nPCR) increased linearly (r = 0.974) from 1.55 ± 0.14 g/kg per day (mean ± SEM) on day 1 to 1.95 ± 0.15 g/kg per day on day 6. The daily urea generation rate (G), determined from the above linear relationship, was utilized to produce BUN versus time curves by the direct quantification method for simulated patients of varying dry weights (50 to 100 kg) who received variable CRRT urea clearances (500 to 2000 ml/h). Steady state BUN versus time profiles for the same simulated patient population treated with IHD regimens (K = 180 ml/min, T = 4 h) of variable frequency were generated by use of a variable volume, single-pool kinetic model. From these profiles, regression lines of required IHD frequency (per week) versus patient weight for desired BUN(a) values of 60, 80, and 100 mg/dl were obtained. Regression lines of required CRRT urea K (ml/h) versus patient weight for desired BUN(s) values of 60, 80, and 100 mg/dl were also generated. For the attainment of intensive IHD metabolic control (BUN(a) = 60 mg/dl) at steady state, a required treatment frequency of 4.4 dialyses per week is predicted for a 50-kg patient. However, the predicts that the same degree of metabolic control cannot be achieved even with daily IHD therapy in patients ≤ 90 kg. On the other hand, for the attainment of intensive CRRT metabolic control (BUN(s) = 60 mg/dl), required urea clearance rates of approximately 900 ml/h and 1900 ml/h are predicted for 50- and 100-kg patients, respectively. This model suggests that, for many patients, rigorous azotemia control equivalent to that readily attainable with most CRRT can only be achieved with intensive that readily IHD regimens. Following prospective clinical validation, this methodology may be a useful RRT prescription tool for critically ill ARF patients.

AB - Renal replacement therapy (RRT) requirements for critically ill patients with acute renal failure (ARF) depend on numerous factors, including the degree of hypercatabolism, patient size, and desired level of metabolic control. However, the current practice at many institutions is to prescribe generally similar amounts of RRT to ARF patients essentially without regard for the above factors. In this study, a computer based model designed to permit individualized RRT prescription to ARF patients was developed. The critical input parameter is the desired level of metabolic control, which is the time-averaged BUN (BUN(a)) or steady-state BUN (BUN(s)) for intermittent hemodialysis (IHD) or continuous RRT (CRRT), respectively. The basis for the model was a group of 20 patients who received uninterrupted CRRT for at least 5 days. In these patients, the normalized protein catabolic rate (nPCR) increased linearly (r = 0.974) from 1.55 ± 0.14 g/kg per day (mean ± SEM) on day 1 to 1.95 ± 0.15 g/kg per day on day 6. The daily urea generation rate (G), determined from the above linear relationship, was utilized to produce BUN versus time curves by the direct quantification method for simulated patients of varying dry weights (50 to 100 kg) who received variable CRRT urea clearances (500 to 2000 ml/h). Steady state BUN versus time profiles for the same simulated patient population treated with IHD regimens (K = 180 ml/min, T = 4 h) of variable frequency were generated by use of a variable volume, single-pool kinetic model. From these profiles, regression lines of required IHD frequency (per week) versus patient weight for desired BUN(a) values of 60, 80, and 100 mg/dl were obtained. Regression lines of required CRRT urea K (ml/h) versus patient weight for desired BUN(s) values of 60, 80, and 100 mg/dl were also generated. For the attainment of intensive IHD metabolic control (BUN(a) = 60 mg/dl) at steady state, a required treatment frequency of 4.4 dialyses per week is predicted for a 50-kg patient. However, the predicts that the same degree of metabolic control cannot be achieved even with daily IHD therapy in patients ≤ 90 kg. On the other hand, for the attainment of intensive CRRT metabolic control (BUN(s) = 60 mg/dl), required urea clearance rates of approximately 900 ml/h and 1900 ml/h are predicted for 50- and 100-kg patients, respectively. This model suggests that, for many patients, rigorous azotemia control equivalent to that readily attainable with most CRRT can only be achieved with intensive that readily IHD regimens. Following prospective clinical validation, this methodology may be a useful RRT prescription tool for critically ill ARF patients.

UR - http://www.scopus.com/inward/record.url?scp=0030733487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030733487&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 804

EP - 812

JO - Journal of the American Society of Nephrology : JASN

JF - Journal of the American Society of Nephrology : JASN

SN - 1046-6673

IS - 5

ER -